Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124508682 | 12450868 | 2 | F | 201503 | 20160621 | 20160609 | 20160705 | EXP | US-ACORDA-ACO_124595_2016 | ACORDA | 60.35 | YR | F | Y | 49.89000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124508682 | 12450868 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, Q 12 HRS | 0000079810 | 22250 | 10 | MG | TABLET | Q12H | |||||
| 124508682 | 12450868 | 2 | SS | ZANAFLEX | TIZANIDINE HYDROCHLORIDE | 1 | UNK | U | U | 0 | CAPSULE | ||||||||
| 124508682 | 12450868 | 3 | SS | TECFIDERA | DIMETHYL FUMARATE | 1 | Oral | 240 MG, BID | 0 | 240 | MG | BID | |||||||
| 124508682 | 12450868 | 4 | C | BACLOFEN. | BACLOFEN | 1 | UNK | U | 0 | ||||||||||
| 124508682 | 12450868 | 5 | C | NUVIGIL | ARMODAFINIL | 1 | UNK | U | 0 | ||||||||||
| 124508682 | 12450868 | 6 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 124508682 | 12450868 | 7 | C | SINEMET | CARBIDOPALEVODOPA | 1 | UNK | U | 0 | ||||||||||
| 124508682 | 12450868 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124508682 | 12450868 | 1 | Gait disturbance |
| 124508682 | 12450868 | 2 | Product used for unknown indication |
| 124508682 | 12450868 | 3 | Multiple sclerosis |
| 124508682 | 12450868 | 4 | Product used for unknown indication |
| 124508682 | 12450868 | 5 | Product used for unknown indication |
| 124508682 | 12450868 | 6 | Product used for unknown indication |
| 124508682 | 12450868 | 7 | Product used for unknown indication |
| 124508682 | 12450868 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124508682 | 12450868 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124508682 | 12450868 | Drug ineffective | |
| 124508682 | 12450868 | Urinary tract infection | |
| 124508682 | 12450868 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |